Sichuan Yixintang Pharmaceutical Chain Co., Ltd. announced that it will receive CNY 100,000,000 in an equity round of funding on February 8, 2018. The transaction will include participation from the returning investor Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. (SZSE:002727). The company's registered capital will increase from CNY 214,000,000 to CNY 314,000,000. The transaction was approved by the board of directors in its 5th session of the company’s 4th directorate.